Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Shireen Kassam is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline
British Society for Haematology, 1 Jun 2022, In: British Journal of Haematology. 197, 5, p. 558-572 15 p.Research output: Contribution to journal › Article › peer-review
Open Access29 Citations (Scopus) -
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
CALM Study Group, Nov 2022, In: The Lancet Haematology. 9, 11, p. e833-e843Research output: Contribution to journal › Article › peer-review
109 Citations (Scopus) -
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
Fattizzo, B., Ireland, R., Dunlop, A., Yallop, D., Kassam, S., Large, J., Gandhi, S., Muus, P., Manogaran, C., Sanchez, K., Consonni, D., Barcellini, W., Mufti, G. J., Marsh, J. C. W. & Kulasekararaj, A. G., Nov 2021, In: Leukemia. 35, 11, p. 3223-3231 9 p.Research output: Contribution to journal › Article › peer-review
Open Access62 Citations (Scopus) -
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
UCART19 Group, 12 Dec 2020, In: The Lancet. 396, 10266, p. 1885-1894 10 p.Research output: Contribution to journal › Article › peer-review
320 Citations (Scopus) -
Outcome for patients with relapsed/refractory aggressive lymphoma treated with gemcitabine and oxaliplatin with or without rituximab; a retrospective, multicentre study
Dhanapal, V., Gunasekara, M., Lianwea, C., Marcus, R., De Lord, C., Bowcock, S., Devereux, S., Patten, P., Yallop, D., Wrench, D., Fields, P. & Kassam, S., 16 Jan 2017, In: Leukemia and Lymphoma. p. 1-9 9 p.Research output: Contribution to journal › Article › peer-review
9 Citations (Scopus)